CD14 and breast cancer: Tumor-infiltrating CD14+CD1c+ DCs have been reported in multiple instances, including ovarian cancer ascites (Segura et al., 2013), breast cancer (Michea et al., 2018), and melanoma (Bakdash et al., 2016; Binnewies et al., 2019).